Join CTTC | Print Page | Contact Us | Sign In
CBMTG Webinar - Dr. Jorge J. Castillo
Tell a Friend About This EventTell a Friend

When: March 6, 2019
12:00pm PT/3:00pm ET
Where: Canada

« Go to Upcoming Event List  

Wednesday, March 6, 2019
12:00pm PT/3:00pm ET

Current Management of Waldenstrom Macroglobulinemia

Jorge J. Castillo, MD (Dana-Farber Cancer Institute, Boston, Massachusetts)

Speaker Biography:
Dr. Castillo was born in Peru, received his medical degree in Mexico City, and completed his Internal Medicine and Hematology & Oncology training at the University of Massachusetts and Brown University, respectively. In 2013, Dr. Castillo was appointed Assistant Professor at Harvard Medical School. Dr. Castillo is the Clinical Director of the Bing Center for Waldenström Macroglobulinemia at the Dana-Farber Cancer Institute, and he sees approximately 1,000 patients with Waldenström Macroglobulinemia per year in his Clinic. Dr. Castillo is also the principal investigator in a series of innovative clinical trials evaluating highly effective non-chemotherapeutic approaches for patients with Waldenström macroglobulinemia. Dr. Castillo is a member of the NCCN Committee for Myeloma, Amyloidosis and Waldenström Macroglobulinemia. He has authored more than 200 peer-reviewed articles, and has published his research in the New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology and Blood.

Learning Objectives:
1. Discuss the biology and pathogenesis of Waldenstrom macroglobulinemia
2. Review clinicopathological features of Waldenstrom macroglobulinemia
3. Provide an update treatment options in Waldenstrom macroglobulinemia, including the role of transplantation



This website is sponsored by an 
unrestricted educational grant from: